OmniGuide Inc., a medical device company specializing in precision surgical energy instruments, recently announced the launch of a next-generation product designed for laparoscopic endometriosis procedures. The instrument set offers enhanced ergonomics, access, and operative flow compared to previous CO2 laser delivery systems.
Dr. Samuel Brown, a Jones Institute graduate, director of Brown Fertility (a large leading Reproductive Endocrinology & Infertility Lab in Jacksonville, Florida), and physician who has performed over 5,000 laparoscopies for fertility-based surgery noted, “The CO2 laser is considered the optimal energy source for endometriosis surgery, but clinical applications were limited due to the cumbersome set-up and inadequate anatomical access associated with older technologies. OmniGuide’s device allows me to operate with the clinical advantages of CO2 laser along with the ergonomics and ease-of-use I expect from advanced laparoscopic instruments. The technology will undoubtedly change the way that endometriosis is treated today, and I am pleased that I can be one of the first to offer it to my patients.”
Scott Flora, President and CEO of OmniGuide, stated, “The launch of the new laparoscopic instrument set is a milestone on OmniGuide’s mission to becoming a leader in minimally invasive surgery. Based on the positive feedback we have received from gynecologists, I am confident that our new instrument set will allow us to establish a strong presence in endometriosis surgery.”
OmniGuide’s gynecologic surgical instruments will be featured at two upcoming conferences: American Society of Reproductive Medicine (October 20-24, San Diego, CA) and American Association for Gynecologic Laparoscopists (November 5-9. Las Vegas, NV). Conference attendees can receive a hands-on demonstration of the technology at OmniGuide’s exhibit booth.
OmniGuide, Inc. is a leader in the development and marketing of precision surgical energy solutions that improve patients’ lives. By leveraging its proprietary flexible CO2 laser technology, OmniGuide products enhance surgical accuracy, access, and control for microsurgical applications, laparoscopy, and robotically assisted surgery. Sold under the BeamPath® brand in the United States through a direct sales force and through distribution partners in Europe, the company is committed to shaping the future of minimally invasive surgery. For more information please visit www.omni-guide.com.